Tuesday, November 24, 2009, 5:42pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

World Heart Corp. (WHRT)

 On Nov 23: 4.50 USD   0.00 (0.00%)  
MORE ON WHRT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
World Heart Corporation (NCM:WHRT) Delayed quote dataEdit
Last Trade: 4.50 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 4.50
Open: N/A
Bid: 3.41 x 1000
Ask: 5.35 x 100
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 1.40 - 8.63
Volume: 0
Avg Vol (3m): 4,913.85
Market Cap: 59.90M
P/E (ttm): N/A
EPS (ttm): -1.56
Div & Yield: N/A (N/A%)
World Heart Corp. (WHRT)
1d  5d  3m  6m  1y  2y  5y  max 
 Add WHRT to Portfolio   Download Data

HEADLINES
• WORLD HEART CORP Financials
EDGAR Online Financials (Fri, Nov 20)
• WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
CNW Group (Tue, Nov 17)
• WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
PRNewswire (Tue, Nov 17)
• WORLD HEART CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
• WorldHeart to Present at Canaccord Adams Cardiovascular Conference
CNW Group (Thu, Nov 5)
• WorldHeart to Present at Canaccord Adams Cardiovascular Conference
PRNewswire (Thu, Nov 5)
• WORLD HEART CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 15)
• WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial
CNW Group (Thu, Oct 15)
• WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial Center On-Site Training Completed
PRNewswire (Thu, Oct 15)
• WORLD HEART CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Sep 24)
More Headlines for WHRT...
ANALYST
EPS Est (next year) () : N/A
EPS Est (in 2 years) () : N/A
Avg Rec (current)*: N/A
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
World Heart Corporation and its subsidiaries engage in the development, production, and sale of ventricular assist devices (VADs). VADs are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow th...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices